Andreea Varga

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Jaume Capdevila, Lori J. Wirth, Thomas Ernst et al. · Journal of Clinical Oncology · 2020 · 335 citations · Full text

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

Capucine Baldini, P. Martin Romano, Anne-Laure Voisin et al. · European Journal of Cancer · 2020 · 80 citations

Aging, Immune Regulation, Immunology +16

Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania

Ioan Ţilea, Dorina Nastasia Petra, Septimiu Voidăzan et al. · Patient Preference and Adherence · 2018 · 55 citations · Full text

Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven

Hassan Izzedine, Bernard Escudier, Philippe Rouvier et al. · Annals of Oncology · 2013 · 44 citations · Full text

Urology, Mtor Inhibitor Therapy, Medicine +8

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone

C. Massard, Joaquı́n Mateo, Yohann Loriot et al. · Annals of Oncology · 2016 · 27 citations · Full text